BREANNE CAFFERY: Open Payments
NPI 1750032116 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 64 payments from 20 companies in 2025. Trend: 2023 $1,154 · 2024 $1,760 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $224 |
| PFIZER INC. | 9 | $171 |
| Lilly USA, LLC | 16 | $148 |
| Novo Nordisk Inc | 5 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Eisai Inc. | 2 | $48 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: NURTEC ODT, FARXIGA, JARDIANCE, MOUNJARO, CAPLYTA, Leqembi, AIRSUPRA, NEXLETOL.
Industry payments across SC — which companies pay providers there.
